José Ramón Arribas

Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19

Christoph D. Spinner, Robert Gottlieb, Gerard J. Criner et al. · JAMA · 2020 · 1.3K citations · Full text

Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV

Joel E. Gallant, Edwin DeJesus, José Ramón Arribas et al. · New England Journal of Medicine · 2006 · 879 citations

Lopinavir–Ritonavir versus Nelfinavir for the Initial Treatment of HIV Infection

Sharon Walmsley, Barry Bernstein, Martin King et al. · New England Journal of Medicine · 2002 · 647 citations

Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain

Juan Berenguer, Pablo Ryan, Jesús Rodríguez‐Baño et al. · Clinical Microbiology and Infection · 2020 · 418 citations · Full text

Long Covid, Global Health, Covid-19 Pandemic +8

Comparison of Changes in Bone Density and Turnover with Abacavir‐Lamivudine versus Tenofovir‐Emtricitabine in HIV‐Infected Adults: 48‐Week Results from the ASSERT Study

Hans‐Jürgen Stellbrink, Chloe Orkin, José Ramón Arribas et al. · Clinical Infectious Diseases · 2010 · 409 citations · Full text